AGP Franklin LLC Takes $1.51 Million Position in Humana Inc. (NYSE:HUM)

AGP Franklin LLC acquired a new position in shares of Humana Inc. (NYSE:HUM) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 5,937 shares of the insurance provider’s stock, valued at approximately $1,506,000.

A number of other hedge funds have also recently added to or reduced their stakes in the stock. FPC Investment Advisory Inc. bought a new stake in shares of Humana during the fourth quarter valued at approximately $27,000. Centricity Wealth Management LLC bought a new position in Humana in the 4th quarter valued at $30,000. LFA Lugano Financial Advisors SA increased its stake in shares of Humana by 56.3% in the 4th quarter. LFA Lugano Financial Advisors SA now owns 125 shares of the insurance provider’s stock valued at $32,000 after buying an additional 45 shares during the period. OFI Invest Asset Management bought a new stake in shares of Humana during the fourth quarter worth $33,000. Finally, Atwood & Palmer Inc. lifted its stake in shares of Humana by 64.5% during the fourth quarter. Atwood & Palmer Inc. now owns 153 shares of the insurance provider’s stock valued at $39,000 after acquiring an additional 60 shares during the period. Institutional investors own 92.38% of the company’s stock.

Humana Price Performance

HUM stock opened at $284.27 on Tuesday. The stock has a market cap of $34.31 billion, a PE ratio of 28.57, a price-to-earnings-growth ratio of 2.05 and a beta of 0.62. The stock has a 50-day moving average price of $265.43 and a two-hundred day moving average price of $270.11. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.68. Humana Inc. has a 1 year low of $213.31 and a 1 year high of $406.46.

Humana (NYSE:HUM) last posted its quarterly earnings data on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. Equities analysts forecast that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be given a dividend of $0.885 per share. The ex-dividend date of this dividend is Friday, March 28th. This represents a $3.54 annualized dividend and a yield of 1.25%. Humana’s dividend payout ratio (DPR) is presently 35.58%.

Wall Street Analysts Forecast Growth

HUM has been the subject of several recent research reports. Royal Bank of Canada reissued an “outperform” rating and set a $283.00 price objective on shares of Humana in a report on Wednesday, February 12th. Barclays boosted their price target on shares of Humana from $270.00 to $322.00 and gave the stock an “equal weight” rating in a research note on Friday. Guggenheim began coverage on shares of Humana in a research note on Wednesday, April 9th. They issued a “buy” rating and a $326.00 price objective on the stock. Morgan Stanley dropped their target price on shares of Humana from $301.00 to $285.00 and set an “equal weight” rating for the company in a research report on Wednesday, February 12th. Finally, Truist Financial raised their price target on Humana from $290.00 to $325.00 and gave the stock a “hold” rating in a research report on Friday. Seventeen research analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $288.60.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.